4.8 Article

Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Materials Science, Biomaterials

Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages

Nhan Phan Tran et al.

Summary: In this study, researchers synthesized a sialic acid-polyethylene glycol conjugate and used it to modify the surface of liposomes, targeting tumor-associated macrophages (TAMs). In vitro and in vivo experiments demonstrated that sialic acid-modified liposomes have higher cellular uptake ability and anti-tumor efficacy.

BIOMATERIALS ADVANCES (2023)

Review Pharmacology & Pharmacy

Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics

Thijs Van de Vyver et al.

Summary: RNA therapeutics have great potential for treating various diseases, but they face challenges in reaching their target sites in cells. Non-viral delivery systems have been developed, but their efficiency is still relatively low. Understanding the intracellular delivery process and finding ways to improve it are crucial for the development of effective RNA delivery carriers.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Chemistry, Multidisciplinary

Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy

Yichao Lu et al.

Summary: Dendritic cells play an important role in the cross presentation of exogenous antigens, contributing to a diversified T-cell activation and efficient anti-tumor immune response. Understanding the mechanisms and regulation strategies of cross presentation by DC populations can lead to better clinical efficacy in antitumor therapy.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Oncology

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Jian Liu et al.

Summary: Research on tumor immunotherapy has made significant progress, and cancer vaccines have emerged as a promising therapeutic strategy. Cancer vaccines stimulate anti-tumor immunity with tumor antigens, potentially overcoming immune suppression and inducing both humoral and cellular immunity. This review introduces the working mechanism of cancer vaccines, summarizes different development platforms, and highlights their clinical research progress, with a focus on clinical application and therapeutic efficacy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Immunology

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine

Chunfeng Li et al.

Summary: The BNT162b2 mRNA vaccine stimulates potent antibody and antigen-specific T cell responses, as well as enhanced innate responses after secondary immunization. Circulating IFN-gamma is mainly produced by natural killer cells and CD8(+) T cells in the draining lymph nodes. The CD8(+) T cell response is dependent on type I interferon-dependent MDA5 signaling.

NATURE IMMUNOLOGY (2022)

Article Immunology

Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting

Harun Achmad et al.

Summary: Cancer immunotherapy aims to eradicate tumors by stimulating the host's anti-tumor immune response. Cancer vaccines have emerged as a promising approach, either alone or in combination with other therapies. Nanoplatforms, such as nanoparticles, cell-derived components, and nanocomplexes, have been developed to deliver vaccine components to target cells and tissues, thereby enhancing anti-tumor efficacy and reducing side effects. Targeting dendritic cells (DCs) with nanovaccines has attracted significant interest. This review provides an overview of nanovaccines in cancer therapy, with a focus on targeting DCs.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Chemistry, Multidisciplinary

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

Yi Ju et al.

Summary: The study found that LNP mRNA vaccines can boost the levels of PEG-specific antibodies, which is associated with systemic reactogenicity and an increase in the association of PEG particles with leukocytes in human blood. The long-term clinical impact of vaccine-induced PEG-specific antibodies should be monitored, and suitable alternatives to PEG should be explored for future LNP vaccines.

ACS NANO (2022)

Article Multidisciplinary Sciences

Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants

Na Fan et al.

Summary: In this study, a novel mRNA delivery system was developed by introducing a STING agonist, manganese, to promote antigen-presenting cell maturation and mRNA expression. mRNA vaccines targeting the Delta and Omicron variants were prepared and both induced specific immune responses with strong neutralization ability and good safety.

SCIENCE ADVANCES (2022)

Article Engineering, Biomedical

Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy

Junqiang Ding et al.

Summary: The study developed a novel nano-platform for tumor therapy by utilizing neutrophils and monocytes as drug carriers, achieving enhanced tumor targeting efficiency through liposome modification. The research provided potential clinical applications and contributed to the development of a new drug delivery platform for cancer treatment.

ACTA BIOMATERIALIA (2021)

Review Biotechnology & Applied Microbiology

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Namit Chaudhary et al.

Summary: mRNA vaccines have been established as a rapid, effective, and safe approach for protecting individuals from infectious diseases, especially during the COVID-19 pandemic. Further research is needed to optimize mRNA vaccine design, delivery, and applications for a range of infectious diseases.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Biochemistry & Molecular Biology

Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes

Xue-hai Liang et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Nanoscience & Nanotechnology

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing

Qiang Cheng et al.

NATURE NANOTECHNOLOGY (2020)

Review Pharmacology & Pharmacy

Lipid nanoparticles for nucleic acid delivery: Current perspectives

Eleni Samaridou et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Pharmacology & Pharmacy

Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions

Wufa Fan et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Article Multidisciplinary Sciences

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Ugur Sahin et al.

NATURE (2020)

Article Medicine, General & Internal

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes

Alsya J. Affandi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Pharmacology & Pharmacy

Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Carla B. Roces et al.

PHARMACEUTICS (2020)

Article Materials Science, Biomaterials

Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy

Cong Li et al.

BIOMATERIALS SCIENCE (2020)

Article Biochemistry & Molecular Biology

Physical Principles of Membrane Shape Regulation by the Glycocalyx

Carolyn R. Shurer et al.

Article Fisheries

Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins

Kim F. Bornhoefft et al.

DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

Marianna Yanez Arteta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Chemistry, Multidisciplinary

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

Matthias A. Oberli et al.

NANO LETTERS (2017)

Article Oncology

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond

Kalijn F. Bol et al.

CLINICAL CANCER RESEARCH (2016)

Review Immunology

Dendritic cell maturation and cross-presentation: timing matters!

Andres Alloatti et al.

IMMUNOLOGICAL REVIEWS (2016)

Article Biotechnology & Applied Microbiology

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Anders Wittrup et al.

NATURE BIOTECHNOLOGY (2015)

Review Chemistry, Multidisciplinary

Metabolism of Nanomaterials in Vivo: Blood Circulation and Organ Clearance

Bing Wang et al.

ACCOUNTS OF CHEMICAL RESEARCH (2013)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

Article Biotechnology & Applied Microbiology

Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape

Jerome Gilleron et al.

NATURE BIOTECHNOLOGY (2013)

Article Chemistry, Multidisciplinary

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives

Huan Xu et al.

JOURNAL OF CONTROLLED RELEASE (2008)